The challenge for the treatment of inflammatory bowel disease (IBD) is the delivery of the
drug to the site of inflammation. Because nanoparticles have the ability to accumulate in …

Allergen-specific immunotherapy was introduced in clinical settings more than 100 years
ago. It remains the only curative approach to treating allergic disorders that ameliorates …

Nanoparticles in allergen immunotherapy : Current Opinion in Allergy and Clinical Immunology
Nanoparticles in allergen immunotherapy : Current Opinion in Allergy and Clinical Immunology …

Amphiphilic cyclodextrin (ACyD) provides water-soluble and adaptable nanovectors by
modulating the balance between the hydrophobic and hydrophilic chains at both CyD sides …

Inflammatory bowel disease (IBD) is a chronic, non-specific inflammatory condition
characterized by recurring inflammation of the intestinal mucosa. However, the existing IBD …

Nanoparticles have gained ground in several fields. However, it is important to consider their
potentially hazardous effects on humans, flora, and fauna. Human exposure to …

Parietaria pollen is the most important cause of pollen allergies in the Mediterranean area,
as Parietaria is widespread in this region. Many issues are associated with Parietaria …

Background Nanomedicine studies have showed a great potential for drug delivery into the
lung. In this manuscript nanostructured lipid carriers (NLC) containing Fluticasone …

A recombinant hybrid composed of the two major allergens of the Parietaria pollen Par j 1
and Par j 2 has been generated by DNA recombinant technology (PjED). This hybrid was …

Allergen specific immunotherapy has been introduced in the clinic more than 100 years ago
showing effectiveness and, so far, it represents the only curative approach to treat allergic …